PAREXEL's picture

Over the past 30 years, PAREXEL has developed significant expertise to assist clients in the worldwide pharmaceutical, biotechnology and medical device industries with the development and launch of their products in order to bring safe and effective treatments to the global marketplace for the patients who need them. Headquartered near Boston, Massachusetts, PAREXEL operates over 78 locations throughout more than 52 countries around the world, and has over 14,400 employees.

We are a leading global bio/pharmaceutical services organization that helps clients expedite time-to-market through our development and launch services. These include a broad range of clinical development capabilities, integrated advanced technologies, regulatory affairs consulting, and commercialization services.

PAREXEL press release, blog etc

03/13/2018 - 09:51 Exploring Our Partnership with CHA Medical Group
03/07/2018 - 12:32 Your clinical trial supply may be at risk Brexit and the impact on IMP distribution
03/01/2018 - 10:58 Generating Evidence to Drive Patient Access
02/14/2018 - 10:23 The Life of a Human Biological Sample: A Look Inside and How to Maintain Its Integrity
02/01/2018 - 07:13 Youre Hot Then Youre Cold -Temperature Management & RTSM Integration
02/01/2018 - 07:12 Aligning on Patient Outcomes How Market Dynamics Can Facilitate RWD (Real World Data) Solutions in Research
12/18/2017 - 08:32 PAREXEL Announces Enhanced Global Data Operations Offering to Drive Efficiencies for Life Science Companies
12/12/2017 - 10:03 PAREXEL Launches Perceptive Cloud for the Life Sciences Industry
11/27/2017 - 00:19 Biosimilar mAbs a unique and distinct market (for the time being?)
11/16/2017 - 14:02 The Impact of the Digital Human Resources Organization on People - Part 1
11/15/2017 - 10:24 PAREXEL Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry
11/15/2017 - 04:02 THE CONNECTED JOURNEY OF DATA-DRIVEN SERVICES Watch the video Read Brochure
11/02/2017 - 10:43 The Evolution of Drug Development & Market Access via Connected Data-driven Solutions
10/26/2017 - 06:28 PAREXEL Enhances Its Active Tracking Service with Bluetooth Capability to Improve Monitoring of Temperature-Controlled Medication
10/24/2017 - 07:40 PAREXEL and Microsoft Form Cloud Technology Alliance Aimed at Accelerating the Pace of Drug Development
09/29/2017 - 12:38 Pamplona Capital Management Completes Acquisition of PAREXEL International
09/24/2017 - 14:16 Improving Site Experience with Risk-Based Monitoring
09/18/2017 - 08:25 PAREXEL International Receives Shareholder Approval for Proposed Acquisition by Pamplona Capital Management